Sjögren's syndrome surgery: Difference between revisions
Jump to navigation
Jump to search
Farima Kahe (talk | contribs) No edit summary |
m Bot: Removing from Primary care |
||
(2 intermediate revisions by 2 users not shown) | |||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The mainstay of treatment for Sjögren's syndrome is medical therapy. Surgery is usually reserved for patients with occlusion of the lacrimal puncta, salivary gland malignancy and recurrent parotitis refractory to medical management. | The mainstay of treatment for Sjögren's syndrome is medical therapy. Surgery is usually reserved for patients with [[occlusion]] of the lacrimal puncta, [[salivary gland]] [[malignancy]] and recurrent [[parotitis]] refractory to medical management. | ||
==Surgery== | ==Surgery== | ||
*The mainstay of treatment for Sjögren's syndrome is medical therapy. Surgery is usually reserved for patients with either:<ref name="pmid24287196">{{cite journal |vauthors=Madero-Visbal R, Milas Z |title=The role of parotidectomy in Sjögren's syndrome |journal=Oral Maxillofac Surg Clin North Am |volume=26 |issue=1 |pages=83–90 |date=February 2014 |pmid=24287196 |doi=10.1016/j.coms.2013.09.007 |url=}}</ref> | *The mainstay of treatment for Sjögren's syndrome is medical therapy. Surgery is usually reserved for patients with either:<ref name="pmid24287196">{{cite journal |vauthors=Madero-Visbal R, Milas Z |title=The role of parotidectomy in Sjögren's syndrome |journal=Oral Maxillofac Surg Clin North Am |volume=26 |issue=1 |pages=83–90 |date=February 2014 |pmid=24287196 |doi=10.1016/j.coms.2013.09.007 |url=}}</ref> | ||
**Occlusion of the lacrimal puncta | **[[Occlusion]] of the [[lacrimal]] puncta | ||
**Recurrent parotitis refractory to medical management | **Recurrent [[parotitis]] refractory to medical management | ||
**Salivary gland malignancy | **[[Salivary gland]] [[malignancy]] | ||
**Severe, refractory pain | **Severe, refractory pain | ||
Line 15: | Line 15: | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Medicine]] | |||
[[Category:Immunology]] | |||
[[Category:Rheumatology]] | [[Category:Rheumatology]] | ||
[[Category: | [[Category:Up-To-Date]] | ||
Latest revision as of 00:12, 30 July 2020
Sjögren's syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Sjögren's syndrome surgery On the Web |
American Roentgen Ray Society Images of Sjögren's syndrome surgery |
Risk calculators and risk factors for Sjögren's syndrome surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Farima Kahe M.D. [2]
Overview
The mainstay of treatment for Sjögren's syndrome is medical therapy. Surgery is usually reserved for patients with occlusion of the lacrimal puncta, salivary gland malignancy and recurrent parotitis refractory to medical management.
Surgery
- The mainstay of treatment for Sjögren's syndrome is medical therapy. Surgery is usually reserved for patients with either:[1]
- Occlusion of the lacrimal puncta
- Recurrent parotitis refractory to medical management
- Salivary gland malignancy
- Severe, refractory pain
References
- ↑ Madero-Visbal R, Milas Z (February 2014). "The role of parotidectomy in Sjögren's syndrome". Oral Maxillofac Surg Clin North Am. 26 (1): 83–90. doi:10.1016/j.coms.2013.09.007. PMID 24287196.